Heze Technology has secured 30 million yuan in angel financing from Kunlun Capital to advance its innovative flexible brain-computer interface technology.
Target Company Overview
Heze Technology (Symbionics), a startup focused on brain-computer interface (BCI) technology, has successfully raised 30 million yuan in its angel round of financing, fully funded by Kunlun Capital. Established in 2023, Heze Technology is at the forefront of developing flexible brain-computer interface devices. This marks a significant advancement in BCI technology, commemorating the 50th anniversary since the original concept of BCIs was introduced in 1973. Historically, progress in BCI technology was hampered by technical limitations; however, advancements in material science and nanotechnology have led to the development of next-generation BCIs capable of facilitating direct communication between carbon-based life forms and silicon-based devices, expanding the boundaries of human cognitive capabilities.
BCI technology exhibits vast applications across various fields, including healthcare, rehabilitation, and entertainment. In the medical field, BCIs can be applied in neural prosthetics and neuro-regulation, assisting individuals with disabilities and neurological disorders to regain normalcy in their lives. In entertainment, BCIs can enhance virtual reality and metaverse experiences, providing consumers with immersive interactions. Furthermore, the potential applications of BCIs extend to military, education, industrial, and security sectors. BCIs can be categorized into non-invasive and invasive types, with non-invasive systems showing early developments but facing limitations due to natural anatomical barriers, leading to signal resolution constraints. Conversely, invasive BCIs, which originated from clinical practices utilizing hard Utah electrodes in the 1990s, have demonstrated various capabilities while also revealing issues such as immune rejection and signal drift, presenting challenges in addressing market demands.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview of Brain-Computer Interfaces in China
China has been increasingly proactive in developing brain-computer interface technologies, receiving substantial government support, illustrated by the launch of the 'China Brain Project' in September 2021. This initiative encompasses 59 research areas, including the study of flexible BCIs, showcasing the country's commitm
Similar Deals
Dingfeng BioCapital and Innovation Works → Heranova Lifesciences Holding
2023
Adicon Holdings Limited → Crown Bioscience Inc.
2026
昆仑资本
invested in
和泽科技
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $4M